274 related articles for article (PubMed ID: 12154108)
1. AT1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats.
Nagata K; Somura F; Obata K; Odashima M; Izawa H; Ichihara S; Nagasaka T; Iwase M; Yamada Y; Nakashima N; Yokota M
Hypertension; 2002 Aug; 40(2):168-74. PubMed ID: 12154108
[TBL] [Abstract][Full Text] [Related]
2. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
[TBL] [Abstract][Full Text] [Related]
3. Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype.
Kim S; Iwao H
J Hypertens Suppl; 1997 Dec; 15(6):S3-7. PubMed ID: 9493120
[TBL] [Abstract][Full Text] [Related]
4. Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K
Circulation; 2002 Sep; 106(13):1722-8. PubMed ID: 12270869
[TBL] [Abstract][Full Text] [Related]
5. Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats.
Obata J; Nakamura T; Takano H; Naito A; Kimura H; Yoshida Y; Shimizu F; Guo DF; Inagami T
J Hypertens; 2000 Sep; 18(9):1247-55. PubMed ID: 10994756
[TBL] [Abstract][Full Text] [Related]
6. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H
Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
[TBL] [Abstract][Full Text] [Related]
7. Calcineurin inhibitor attenuates the development and induces the regression of cardiac hypertrophy in rats with salt-sensitive hypertension.
Shimoyama M; Hayashi D; Zou Y; Takimoto E; Mizukami M; Monzen K; Kudoh S; Hiroi Y; Yazaki Y; Nagai R; Komuro I
Circulation; 2000 Oct; 102(16):1996-2004. PubMed ID: 11034951
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats.
Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Ishimura Y; Chatani F; Iwao H
J Pharmacol Exp Ther; 1995 Apr; 273(1):509-15. PubMed ID: 7714806
[TBL] [Abstract][Full Text] [Related]
9. Augmented diurnal variations of the cardiac renin-angiotensin system in hypertensive rats.
Naito Y; Tsujino T; Fujioka Y; Ohyanagi M; Iwasaki T
Hypertension; 2002 Dec; 40(6):827-33. PubMed ID: 12468565
[TBL] [Abstract][Full Text] [Related]
10. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
Nagata K; Obata K; Xu J; Ichihara S; Noda A; Kimata H; Kato T; Izawa H; Murohara T; Yokota M
Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
[TBL] [Abstract][Full Text] [Related]
11. Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts.
Yamamoto K; Masuyama T; Sakata Y; Mano T; Nishikawa N; Kondo H; Akehi N; Kuzuya T; Miwa T; Hori M
Cardiovasc Res; 2000 Aug; 47(2):274-83. PubMed ID: 10946064
[TBL] [Abstract][Full Text] [Related]
12. Prevention of salt-induced hypertension and fibrosis by AT1-receptor blockers in Dahl S rats.
Liang B; Leenen FH
J Cardiovasc Pharmacol; 2008 May; 51(5):457-66. PubMed ID: 18418273
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats.
Makino N; Sugano M; Otsuka S; Hata T
Hypertension; 1997 Oct; 30(4):796-802. PubMed ID: 9336375
[TBL] [Abstract][Full Text] [Related]
14. Additive beneficial effects of the combination of a calcium channel blocker and an angiotensin blocker on a hypertensive rat-heart failure model.
Kim-Mitsuyama S; Izumi Y; Izumiya Y; Yoshida K; Yoshiyama M; Iwao H
Hypertens Res; 2004 Oct; 27(10):771-9. PubMed ID: 15785013
[TBL] [Abstract][Full Text] [Related]
15. Effects of AT1 receptor antagonist and spironolactone on cardiac expression of ET-1 mRNA in SHR-SP/Izm.
Naruse M; Tanabe A; Hara Y; Takagi S; Imaki T; Takano K
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S1-3. PubMed ID: 15838251
[TBL] [Abstract][Full Text] [Related]
16. Postovariectomy hypertension is linked to increased renal AT1 receptor and salt sensitivity.
Harrison-Bernard LM; Schulman IH; Raij L
Hypertension; 2003 Dec; 42(6):1157-63. PubMed ID: 14610098
[TBL] [Abstract][Full Text] [Related]
17. Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis.
Tokuda K; Kai H; Kuwahara F; Yasukawa H; Tahara N; Kudo H; Takemiya K; Koga M; Yamamoto T; Imaizumi T
Hypertension; 2004 Feb; 43(2):499-503. PubMed ID: 14699000
[TBL] [Abstract][Full Text] [Related]
18. Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy.
Takeda Y; Yoneda T; Demura M; Usukura M; Mabuchi H
Circulation; 2002 Feb; 105(6):677-9. PubMed ID: 11839620
[TBL] [Abstract][Full Text] [Related]
19. Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart.
Yamamoto K; Masuyama T; Sakata Y; Nishikawa N; Mano T; Yoshida J; Miwa T; Sugawara M; Yamaguchi Y; Ookawara T; Suzuki K; Hori M
Cardiovasc Res; 2002 Jul; 55(1):76-82. PubMed ID: 12062710
[TBL] [Abstract][Full Text] [Related]
20. Cardiac hypertrophy and cardiac renin-angiotensin system in Dahl rats on high salt intake.
Zhao X; White R; Van Huysse J; Leenen FH
J Hypertens; 2000 Sep; 18(9):1319-26. PubMed ID: 10994763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
